← Open Payments lookup

AMARIS BELL: Open Payments

NPI 1811394760 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,014 in 104 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $292 · 2025 $2,014

Food & beverage: $2,014
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.27$423
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)29$374
ABBVIE INC.17$318
Teva Pharmaceuticals USA, Inc.10$309
E.R. Squibb & Sons, L.L.C.7$225
Neurocrine BioSciences, Inc.3$87
Janssen Pharmaceuticals, Inc2$74
Indivior Inc.3$68
Alkermes, Inc.3$61
Takeda Pharmaceuticals U.S.A., Inc.2$47

Products named: CAPLYTA, VRAYLAR, REXULTI, COBENFY, ABILIFY ASIMTUFII, UZEDY, AUSTEDO XR, INGREZZA.

Industry payments across NV — which companies pay providers there.